NDC 65293-001

Angiomax

Bivalirudin

Angiomax is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by The Medicines Company. The primary component is Bivalirudin.

Product ID65293-001_3656c3c3-02e5-42cf-a73e-53a681d11340
NDC65293-001
Product TypeHuman Prescription Drug
Proprietary NameAngiomax
Generic NameBivalirudin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2000-12-15
Marketing CategoryNDA / NDA
Application NumberNDA020873
Labeler NameThe Medicines Company
Substance NameBIVALIRUDIN
Active Ingredient Strength250 mg/1
Pharm ClassesAnti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 65293-001-01

10 VIAL, SINGLE-USE in 1 CARTON (65293-001-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
Marketing Start Date2000-12-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65293-001-01 [65293000101]

Angiomax INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA020873
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2000-12-15

Drug Details

Active Ingredients

IngredientStrength
BIVALIRUDIN250 mg/1

OpenFDA Data

SPL SET ID:911cd48f-01ea-4dec-b30c-95e7e0ea9d2a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 284534
  • 308769
  • UPC Code
  • 0365293001012
  • Pharmacological Class

    • Anti-coagulant [EPC]
    • Direct Thrombin Inhibitor [EPC]
    • Thrombin Inhibitors [MoA]

    NDC Crossover Matching brand name "Angiomax" or generic name "Bivalirudin"

    NDCBrand NameGeneric Name
    0781-3447Angiomaxbivalirudin
    65293-001Angiomaxbivalirudin
    0409-8300BivalirudinBIVALIRUDIN
    0781-3158bivalirudinbivalirudin
    0781-9158bivalirudinbivalirudin
    16729-275BivalirudinBivalirudin
    25021-405bivalirudinbivalirudin
    52958-034BivalirudinBivalirudin
    55111-652BivalirudinBivalirudin
    55150-210BIVALIRUDINBIVALIRUDIN
    60505-6101Bivalirudinbivalirudin
    63323-562BivalirudinBivalirudin
    67457-256Bivalirudinbivalirudin
    69097-601bivalirudinbivalirudin

    Trademark Results [Angiomax]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ANGIOMAX
    ANGIOMAX
    75758548 2427591 Live/Registered
    SANDOZ INC.
    1999-07-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.